Home > Resources > Infographics > CAPTIVATING STATISTICS ON WHY YOU NEED ABM RIGHT NOW

CAPTIVATING STATISTICS ON WHY YOU NEED ABM RIGHT NOW

September 2, 2019

Increase in opportunities using ABM programs, according to Gartnerof business buyers conduct more than half of their research online before making an offline purchase (Forrester). Worth wasted in marketing efforts due to misalignment between marketing and sales (Hubspot) of B2B companies have staff that are fully or partially dedicated to ABM programs (SiriusDecisions). Increase in Annual Contract Value (ACV) for companies that implemented ABM (TOPO).

Spotlight

Lantern Pharma Inc

Lantern Pharma Inc is a multinational drug development company that harnesses the power of technology to identify patient subgroups that respond best to new drug therapeutics and bring them to the market in a timely and cost sensitive manner.

Other Infographics

Next-Gen Genetics: Cancer Therapies Create Investment Prospects

Infographic | August 12, 2022

The field (gene therapy) is not standing still, it’s evolving rapidly. If we have this discussion again in 18 months’ time, I don't know what we’ll be using then.

Designing Genetic Circuit

Infographic | April 13, 2020

Near the turn of the millennium, James Collins and Stanislas Leibler independently undertook rather similar projects: design what would become synthetic biology’s seminal genetic circuits. And they came up with strikingly similar action plans—use E. coli to pair promoters with repressors that control one another’s behavior.

RNA sequencing libraries

Infographic | April 7, 2020

As part of our In Focus on RNA sequencing for cancer research, we put together an infographic to provide top tips on the preparation of RNA sequencing libraries, the best metrics to use when analyzing your libraries and suggestions for efficient and effective kits for the preparation of each library type.

Merck’s 23 CRISPR Patents Leading the way in genome-editing technology

Infographic | April 7, 2020

CRISPR Integration: CRISPR/Cas9 System for insertion in eukaryotic cells Compositions and use of CRISPR/Cas9 to integrate a new sequence of DNA after cutting genomic DNA. CRISPR-chrom: Improves access to the genome so that CRISPR-driven edits can be done more efficiently.